FDA NDC Directory · JSON-LD · Markdown

Mounjaro

NDC 0002-2214 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nametirzepatide
Labeler / ManufacturerEli Lilly and Company
Marketing categoryNew Drug Application (innovator) · App NDA215866
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsTIRZEPATIDE (7.5 mg/.5mL)
Marketing started20230728
Package count1

External sources

Source: openFDA. Public-domain (CC0).